Gadolinium Is Not the Only Trigger for Nephrogenic Systemic Fibrosis: Insights From Two Cases and Review of the Recent Literature
Open Access
- 1 October 2007
- journal article
- case report
- Published by Elsevier in American Journal of Transplantation
- Vol. 7 (10) , 2425-2432
- https://doi.org/10.1111/j.1600-6143.2007.01941.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosisJournal of the American Academy of Dermatology, 2007
- Nephrogenic Systemic FibrosisClinical Journal of the American Society of Nephrology, 2007
- Nephrogenic Systemic FibrosisInvestigative Radiology, 2007
- Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition?The British Journal of Radiology, 2007
- A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosisNature Clinical Practice Nephrology, 2007
- The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy--report of two cases and review of the literatureNephrology Dialysis Transplantation, 2006
- Nephrogenic Fibrosing Dermopathy/Nephrogenic Systemic Fibrosis: Report of a New Case With Literature ReviewAmerican Journal of Kidney Diseases, 2005
- Dialysis‐associated systemic fibrosis (nephrogenic fibrosing dermopathy): Study of inflammatory cells and transforming growth factor β1 expression in affected skinArthritis & Rheumatism, 2004
- Presence of CD45RO+ CD34+ cells with collagen synthesis activity in nephrogenic fibrosing dermopathy: a new pathogenic hypothesisBritish Journal of Dermatology, 2004
- Scleromyxoedema-like cutaneous diseases in renal-dialysis patientsPublished by Elsevier ,2000